Terumo Corporation   Report issue

For profit Phase 4
Founded: Tokyo Japan (1921)
Status: No NME R&D (1921)

Organization Overview

First Clinical Trial
2014
NCT02193971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Terumo Corporation | Terumo Medical Corporation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Myocardial Ischemia (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7